Unfortunately, thousands of patients visit hospitals each year only to find out they have cancer. Considering this to be conventional wisdom, cancer remains a debilitating and potentially life-threatening medical condition. Moreover, many families have to deal with covering the costs of their expenses. Oftentimes, these families lack the resources to address the situation. Fortunately, Cancer Treatment Centers of America exceed the expectations of its industry. Each day, the center works effortlessly to address the concerns of their patients and find solutions. Moreover, the company has a consistent track record with proven results.
In recent news, Cancer Treatment Centers of America have collaborated with NantHealth and Allscripts. The purpose of the collaboration remains to implement a custom technical solution platform. Moreover, the platform utilizes eviti. In addition, eviti remains a Nanthealth base solution that accesses clinical records and workflows in the Allscripts record system. Moreover, it was previously unheard of. What makes eviti so effective is its ability to effortlessly integrate the clinical decision support solution. As a result, the Clinical Pathways program assists in informing the cancer treatment process. Moreover, it does not interrupt the physician’s clinical workflow.
For those unaware, Cancer Treatment Centers of America remain headquartered in Boca Raton, Florida. Moreover, it remains a group of five hospitals committed to serving adult patients that remain combating cancer. In addition, Cancer Treatment Centers of America offer a unifying approach to cancer care. It works by combining advancements in genomic testing, precision cancer, and so forth.
Also, CTCA helps patients from all around the world at their numerous hospital locations. This includes Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. In addition, the center boasts some of the highest ratings in its industry. Their quality of customer care and patient experience remains superfluous. To conclude, CTCA remains a leader in their industry.